Joerg H. Eckert

Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial

Fernando J. Martínez, Gerard J. Criner, Margret Jandl et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 45 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

Vivek Khanna, Gregory Feldman, Selwyn Spangenthal et al. · International Journal of COPD · 2016 · 24 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study

Edward Kerwin, Thomas M. Siler, Phillip E. Korenblat et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2016 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3)

Donald A. Mahler, Alex H. Gifford, Aditi Satti et al. · Respiratory Medicine · 2016 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15